Overview
Gerrit Schuster-John practices practicing medicine in Neuherberg, Germany.
Mr. Schuster-John is highly rated in 1 condition, according to our data. His clinical expertise encompasses Emphysema and Chronic Obstructive Pulmonary Disease (COPD).
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Gerrit Schuster-John
Is Gerrit Schuster-John a top-rated expert for Emphysema?
MediFind is an objective health platform that identifies experts based on real-world data. Gerrit Schuster-John is classified as an Advanced expert for Emphysema, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Gerrit Schuster-John participate in research or clinical trials?
Yes. Gerrit Schuster-John has published 11 articles and abstracts on conditions like Emphysema. You can view a list of Gerrit Schuster-John's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EmphysemaMr. Schuster-John isAdvanced. Learn about Emphysema.
- Experienced
- Chronic Obstructive Pulmonary Disease (COPD)Mr. Schuster-John isExperienced. Learn about Chronic Obstructive Pulmonary Disease (COPD).